1. Home
  2. MNMD vs TROO Comparison

MNMD vs TROO Comparison

Compare MNMD & TROO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mind Medicine (MindMed) Inc.

MNMD

Mind Medicine (MindMed) Inc.

HOLD

Current Price

$12.61

Market Cap

960.2M

Sector

Health Care

ML Signal

HOLD

Logo TROOPS Inc.

TROO

TROOPS Inc.

HOLD

Current Price

$1.65

Market Cap

151.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNMD
TROO
Founded
2019
2005
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
960.2M
151.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MNMD
TROO
Price
$12.61
$1.65
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$25.78
N/A
AVG Volume (30 Days)
1.5M
55.8K
Earning Date
11-06-2025
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$15,084,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
247.24
52 Week Low
$4.70
$0.49
52 Week High
$14.43
$2.62

Technical Indicators

Market Signals
Indicator
MNMD
TROO
Relative Strength Index (RSI) 55.67 70.41
Support Level $12.19 $1.21
Resistance Level $13.45 $1.75
Average True Range (ATR) 0.70 0.18
MACD 0.08 0.04
Stochastic Oscillator 72.07 86.89

Price Performance

Historical Comparison
MNMD
TROO

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

Share on Social Networks: